Daihan Pharmaceutical Market Cap

Daihan Pharmaceutical has a market cap or net worth of 145.24 billion as of June 24, 2026. Its market cap has decreased by -13.33% in one year.

Market Cap

145.24B

Enterprise Value

46.62B

Revenue

211.44B

Ranking

n/a

PE Ratio

5.38

Stock Price

24,700.00

Market Cap Chart

Since March 1, 2001, Daihan Pharmaceutical's market cap has increased from 22.26B to 145.24B, an increase of 552.45%. That is a compound annual growth rate of 7.69%.

Market Cap History

Date	Market Cap	% Change
Jun 24, 2026	145.24B	-15.56%
Dec 30, 2025	171.99B	11.64%
Dec 30, 2024	154.06B	-5.59%
Dec 28, 2023	163.17B	-11.13%
Dec 29, 2022	183.60B	6.62%
Dec 30, 2021	172.20B	-12.90%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Daewon Pharmaceutical	177.68B
JW Lifescience	173.89B
Hana Pharm	158.53B
Jeil Pharmaceutical Co.,Ltd	149.07B
CMG Pharmaceutical	147.99B
Samil Pharmaceutical Co.,Ltd	144.15B
Ilyang Pharmaceutical Co.,Ltd	141.07B
Dongwha Pharm.Co.,Ltd	139.42B

Market Cap Rankings